Important: Therapy
Amoxicillin oral 500mg 8 hourly
We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.
Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
Duration 5 days then review.
Amoxicillin oral 500mg 8 hourly
Doxycycline oral 200mg on first day then 100mg daily
Co-Amoxiclav IV 1.2g 8 hourly
+
Clarithromycin IV 500mg 12 hourly
(Clarithromycin IV should only rarely be necessary in COPD)
Penicillin allergy – Discuss with Consultant Microbiologist
Ciprofloxacin 750mg oral 12 hourly
(use IV route 400mg only if oral not possible)
Patients with two or more of the three cardinal signs may benefit from treatment with antimicrobials
Antimicrobials should be tailored against previous isolates where possible.
Consider sending a throat swab in viral transport medium for respiratory viral studies.
Fluroquinolones
Refer to important safety information for all quinolones prior to prescribing.
See MHRA Drug Safety Update January 2024: Fluoroquinolones must only be used in situations when other antibiotics, that are commonly recommended for the infection, are inappropriate such as: